RTW Venture Fund Limited Publication of Circular & Convening of EGM (1152I)
2022年12月1日 - 04:00PM
RNSを含む英国規制内ニュース (英語)
TIDMRTW
RNS Number : 1152I
RTW Venture Fund Limited
01 December 2022
LEI: 549300Q7EXQQH6KF7Z84
1 December 2022
RTW Venture Fund Limited
Publication of Circular & Convening of EGM
Further to the announcement on 28 November 2022, RTW Venture
Fund Limited (the "Company") announces that documentation has been
filed with the U.S. Internal Revenue Service to change the
Company's tax status, with effect from 1 December 2022, from a
"publicly traded partnership" or "PTP" to a corporation for U.S.
federal tax purposes ("Tax Election").
A shareholder circular (the "Circular") has been published today
on the Company's website at www.rtwfunds.com/venture-fund . In
addition, a copy of the Circular has been submitted to the National
Storage Mechanism and will shortly be available for viewing online
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
A notice of an Extraordinary General Meeting ("EGM") is
contained in the Circular. At the EGM, Shareholders will be asked
(a) to approve the adoption of new articles of incorporation, which
will be updated to reflect the U.S. federal tax status of the
Company following completion of the Tax Election and the
reorganisation; and (b) to ratify the decision of the Board to make
the Tax Election.
This information is not intended to be all-inclusive or to
render specific professional tax advice. Shareholders are urged to
consult with their independent tax advisors to determine the tax
consequences. The Company does not provide tax or legal advice.
For Further Information:
RTW Investments, LP +44 (0) 77 1741 7711
Woody Stileman, Managing Director
Buchanan +44 (0)20 7466 5107
Charles Ryland
Henry Wilson
George Beale
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds
Jérémie Birnbaum
James Bouverat (Sales)
BofA Securities +44 (0) 20 7628 1000
Edward Peel
Kieran Millar
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief
Executive Officer
Sadie Morrison, Managing Director
Morgan Stanley Fund Services USA
LLC +1 (914) 225 8885
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment
fund focused on identifying transformative assets with high growth
potential across the biopharmaceutical and medical technology
sectors. Driven by a long-term approach to support innovative
businesses, RTW Venture Fund invests in companies developing
next-generation therapies and technologies that can significantly
improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a
leading healthcare-focused entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more
information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFDDFDSEESEDF
(END) Dow Jones Newswires
December 01, 2022 02:00 ET (07:00 GMT)
Rtw Biotech Opportunities (LSE:RTW)
過去 株価チャート
から 2 2024 まで 3 2024
Rtw Biotech Opportunities (LSE:RTW)
過去 株価チャート
から 3 2023 まで 3 2024